do i need to taper off semaglutide Weaning GLP-1 Medications: A Sustainable Approach Long Term GLP-1 Use: Maintenance

The purpose of this article is not to sway you one way or the other, but rather to provide an understanding of some potential mental health implications associated with these drugs

The SURMOUNT-1 trial reported average reductions of up to 22% with tirzepatide over 72 weeks

The SURMOUNT and SURPASS studies that demonstrated 15% to 21% body weight reduction over 72 weeks were conducted exclusively with Eli Lilly manufactured tirzepatide, not compounded versions

, 1994, vol

The recent availability of generics has certainly accelerated interest, but these are not lifestyle or cosmetic drugs for indiscriminate weight loss